Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
Biotle Biotechnology (Hangzhou) Co., Ltd. — Rare Disease Pipeline | Kisho | Kisho
Biotle Biotechnology (Hangzhou) Co., Ltd.
Other
1
Orphan Designations
0
FDA Approvals
1
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
plasma cell myeloma
a recombinant tri-specific T cell engager (TCE) targeting the T cell antigen CD3, BCMA and GPRC5D
Orphan Designation
-
← Back to Companies
